Anxiety or restlessness occasionally accompanies nausea or appetite suppression, especially at higher doses
Activation of GLP-1R also promotes beta cell survival, inhibits gastric emptying, regulates food intake and reduces appetite (1, 5), making it a key pharmacological target for various metabolic disorders including type 2 diabetes (T2D) and obesity (6, 7)
Its also easy to use, requiring only one injection per week, making it a convenient option for those looking for a lasting weight loss solution
Activated GLP1R stimulates the adenylyl cyclase which catalyzes ATP into cAMP
Von der Diabetes-Behandlung zur Abnehmspritze Die Wirkstoffe Liraglutid, Semaglutid sowie Tirzepatid wurden ursprnglich nur zur Behandlung von Typ-2-Diabetes zugelassen